Zealand Pharma A/S
ZLDPF- Exchange
- OTC
- SEC CIK
- 0002068427
No open-market purchases or sales by Zealand Pharma A/S insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Zealand Pharma A/S as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −2 vs. Q2 2021
- Shares held
- 774.9K
- −561.6K (−42.0%) vs. Q2 2021
- Total value
- $22.0M
- −$17.5M (−44.3%) vs. Q2 2021
- New holders
- 1
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZLDPF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $243 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Zealand Pharma A/S; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 510,000 | $14.3M | 0.08% | 00.0% | Unchanged |
| Bank of America Corp | 151,134 | $4.45M | 0.00% | +150,736+37,873.4% | Added |
| Wellington Management Group LLP | 71,040 | $1.99M | 0.00% | −678,578−90.5% | Reduced |
| AWM Investment Company, Inc. | 19,981 | $560.0K | 0.05% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,032 | $295.0K | 0.00% | −22,178−68.9% | Reduced |
| Morgan Stanley | 6,553 | $193.0K | 0.00% | +463+7.6% | Added |
| BlackRock Inc. | 4,028 | $119.0K | 0.00% | +1,095+37.3% | Added |
| Jacobi Capital Management LLC | 936 | $28.0K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 561 | $17.0K | 0.00% | −10−1.8% | Reduced |
| Signaturefd, LLC | 167 | $5.00K | 0.00% | +167 | New |
| UBS Group AG | 144 | $4.00K | 0.00% | +114+380.0% | Added |
| Lindbrook Capital, LLC | 121 | $4.00K | 0.00% | +73+152.1% | Added |
| Wells Fargo & Company | 100 | $3.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 63 | $2.00K | 0.00% | 00.0% | Unchanged |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −12,603−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −867−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −58−100.0% | Sold out |